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ABSTRACT 
Background and Aim 
 PE (preeclampsia) is defined as new-onset hypertension and new onset 
proteinuria occurring after 20 weeks of pregnancy or maternal organ 
dysfunction, such as renal insufficiency, liver involvement, neurological or 
haematological complications, uteroplacental dysfunction, or foetal growth 
restriction. The incidence of PE in the south Indian population is determined 
as 4-5%. PE is a leading cause of maternal mortality, causing an estimated 
>60,000 maternal deaths worldwide per year. The pathogenesis of PE remains 
largely unknown, the leading hypotheses being the occurrence of a disturbed 
placental function in early pregnancy, with the development of maternal 
syndrome of PE in late pregnancy. In normal pregnancy physiological 
changes happen with hemostatic system, which gets exaggerated in PE and 
turns pathological leading to systematic disorders of metabolism as well as 
multiple organ dysfunctions and may even threaten maternal and foetal lives. 
Hence in our study we aimed to evaluate the coagulation profile and 
transfusion support in PE. 
Materials and Methods 
The study comprised of pregnant women at 24-27 weeks gestation 
(midpregnancy) with normotensive and PE cases of 30 and 50 respectively. In 
our study we did the comparison of Platelet Indices and Coagulation 
Parameters between the control population and PE cases. These parameters 
were observed initially at midpregnancy and again at the time of admission 
for delivery. The cases were categorized as PE with severe features (n=22) 
and PE without severe features (n=28) as per ACOG Guidelines on 
Hypertension in Pregnancy. 
Results 
The coagulation parameter values and platelet indices at midpregnancy 
of PE cases with and without severity were observed to be within normal 
range of values obtained from control subjects. Whereas when comparing the 
late pregnancy parameters between the normal pregnancy and PE with severe 
features significant changes noted with PLT, MPV,PDW, APTT, TT and 
S.Fibrinogen. The predictor of severity of PE was analysed with ROC curve 
by plotting the parameters of PE without severe features and PE with severe 
features. The deranged coagulation profile happened with 11 of the severe PE 
cases (50%). 4 out of these 11 cases developed complications and rescued 
with blood component support. 
Conclusion 
In our study on evaluation of coagulation profile and transfusion 
support in preeclampsia cases, we observed a significant association between 
altered coagulation profile and the severity of cases in late pregnancy. 
However, these parameters can act only as an indirect predictor along with the 
severity of symptoms of PE in deciding prophylactic transfusion support. 
Analysis of these parameters with ROC curve yielded serum fibrinogen and 
PDW as a significant predictor of severity.  
 
 
